Pharmaceutical Benefits Scheme (PBS)

How do I access the PBS?

If you're a healthcare professional, chances are you've heard of the Patient Protection and Affordable Care Act (PPACA), also known as Obamacare. One of the key provisions of the PPACA is the Patient-Centered Outcomes Research Institute (PCORI), which is responsible for funding comparative effectiveness research (CER). The Patient-Centered Outcomes Research Trust Fund, which is funded by a fee on health insurance plans and self-insured health plans, provides the money for PCORI.

One of the ways that PCORI funds CER is through the Patient-Based Comparative Effectiveness Research (PBCER) Program. The PBCER Program funds studies that compare the effectiveness of different medical interventions in real-world settings. In order to be eligible for funding, studies must be designed to answer questions that are important to patients, caregivers, and clinicians.

The PBCER Program is administered by the Patient-Centered Outcomes Research Institute (PCORI) Board of Governors. The Board of Governors is responsible for setting the priorities for the PBCER Program and for selecting the studies that will be funded.

If you are a healthcare professional interested in applying for funding through the PBCER Program, you can find more information on the PCORI website.

What are the eligibility criteria for the PBS?

The Pharmaceutical Benefits Scheme (PBS) is a government-funded program that provides subsidised access to a range of essential medicines. The PBS is an important part of Australia's health care system, ensuring that all Australians have equitable and affordable access to a wide range of quality medicines.

To be eligible for the PBS, a medicine must be listed on the PBS schedule. The PBS schedule is a list of medicines that are subsidised by the Australian Government. To be listed on the PBS schedule, a medicine must be:

  • clinically effective
  • cost-effective
  • safe

In addition, the PBS schedule is reviewed regularly and new medicines are added to the list based on the recommendations of the Pharmaceutical Benefits Advisory Committee (PBAC).

The PBS provides subsidised access to a wide range of essential medicines, including:

  • cancer medicines
  • HIV/AIDS medicines
  • mental health medicines
  • pain medicines
  • medicines for rare diseases

The PBS is an important part of Australia's health care system, ensuring that all Australians have equitable and affordable access to a wide range of quality medicines.

What is the Pharmaceutical Benefits Scheme (PBS)?

The Pharmaceutical Benefits Scheme (PBS) is a government-funded program that provides subsidised access to a range of prescription medications in Australia. The PBS is administered by the Department of Health and is available to all Australian residents and eligible visitors.

The PBS covers a wide range of medications, including those used to treat a variety of conditions such as cancer, heart disease, mental health disorders and infectious diseases. PBS-listed medications are available through pharmacies and other approved outlets, such as hospitals and community health centers.

The cost of PBS-listed medications is typically lower than the cost of medications that are not listed on the PBS. This is because the Australian government subsidises the cost of PBS-listed medications, making them more affordable for patients.

The PBS is an important part of the Australian healthcare system, providing affordable access to essential medications for all Australians.